These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5433843)

  • 1. A clinical physiologic study of hydroxyethyl starch.
    Metcalf W; Papadopoulos A; Tufaro R; Barth A
    Surg Gynecol Obstet; 1970 Aug; 131(2):255-67. PubMed ID: 5433843
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of a new plasma expander, hydroxyethyl starch. 2. Study of its effects on serum enzymes, liver function, erythrocyte sedimentation and kidney function and evaluation of its adverse effects].
    Amakata Y; Hara M; Umemoto Y; Tanaka K; Kosaki G
    Masui; 1972 Jan; 21(1):40-5. PubMed ID: 5063390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of hydroxyethyl starch in the plasma and urine of man following intravenous infusion].
    Oda A; Aoki A; Ozaki T; Unno K; Nagai N
    Masui; 1972 Aug; 21(8):747-53. PubMed ID: 4674920
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
    Mishler JM
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental and clinical study of a plasma expander (hydroxyethyl starch)--comparison with dextran 70 and MF-gelatine].
    Goto Y; Kimura H; Matsumoto K; Yamahara T; Nagata M
    Masui; 1971 Nov; 20(12):1114-23. PubMed ID: 5169830
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of an equal volume replacement with 500 mL 6% hydroxyethyl starch on the blood and plasma volume of healthy volunteers.
    Mortelmans Y; Merckx E; van Nerom C; Verbruggen A; van Aken H; de Roo M; Mortelmans L
    Eur J Anaesthesiol; 1995 May; 12(3):259-64. PubMed ID: 7543845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical study of hydroxyethyl starch.
    Kitamura Y; Yamada A; Sha N; Hamai R; Nishimura K
    Osaka City Med J; 1972; 18(1):21-36. PubMed ID: 4665972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hydroxyethyl starch--an interim report].
    Weidhase R; Faude K; Weidhase R
    Anaesthesiol Reanim; 1998; 23(1):4-14. PubMed ID: 9553245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIRCULATORY RESPONSES TO INTRAVENOUS INFUSIONS OF HYDROXYETHYL STARCH SOLUTIONS.
    THOMPSON WL; WALTON RP
    J Pharmacol Exp Ther; 1964 Dec; 146():359-64. PubMed ID: 14254330
    [No Abstract]   [Full Text] [Related]  

  • 10. Red blood cell depletion with a semiautomated system or hydroxyethyl starch sedimentation for routine cord blood banking: a comparative study.
    Solves P; Mirabet V; Planelles D; Blasco I; Perales A; Carbonell-Uberos F; Soler MA; Roig R
    Transfusion; 2005 Jun; 45(6):867-73. PubMed ID: 15934983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
    Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W; Pölz W; Colombo T; Steindorfer P
    Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental and clinical investigations on the method of analysis of hydroxyethyl starch and its absorption from the blood].
    Kono K; Nagai N; Niimura K; Shimizu M; Oda A
    Masui; 1972 Sep; 21(9):860-8. PubMed ID: 4675566
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
    Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELPHALAN IN THE TREATMENT OF MYELOMATOSIS.
    SPEED DE; GALTON DA; SWAN A
    Br Med J; 1964 Jun; 1(5399):1664-9. PubMed ID: 14147744
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers.
    James MF; Latoo MY; Mythen MG; Mutch M; Michaelis C; Roche AM; Burdett E
    Anaesthesia; 2004 Aug; 59(8):738-42. PubMed ID: 15270962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood values in young gray seals.
    Greenwood AG; Ridgway SH; Harrison RJ
    J Am Vet Med Assoc; 1971 Sep; 159(5):571-4. PubMed ID: 5571825
    [No Abstract]   [Full Text] [Related]  

  • 19. Haematological aspects of Indian kalaazar.
    Chatterjea JB; Sen Gupta PC
    J Indian Med Assoc; 1970 Jun; 54(12):541-52. PubMed ID: 5503461
    [No Abstract]   [Full Text] [Related]  

  • 20. The blood of the normal beagle.
    Michaelson SM; Scheer K; Gilt S
    J Am Vet Med Assoc; 1966 Mar; 148(5):532-4. PubMed ID: 5917435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.